M&A Talks Europe

5. Sanofi spin-off: bidding war over the future of Pharma

30 min · 14 okt 2024
aflevering 5. Sanofi spin-off: bidding war over the future of Pharma artwork

Beschrijving

In this episode of M&A Talks Europe, we dive into the high-stakes battle between private equity giants for Sanofi’s consumer medicine division, Opella, ultimately won by American CD&R for €15.5 billion. We’ll explore how this deal fits into broader trends in both the pharmaceutical and private equity sectors, Sanofi’s shift to biopharma, and the political uproar in France over healthcare sovereignty because of sale of Doliprane, most popular medicine in France. Tune in to learn more about pharma and carve-out deals!

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de M&A Talks Europe community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

5 afleveringen